1. Home
  2. ABSI

as of 03-20-2026 3:43pm EST

$2.91
$0.17
-5.52%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Founded: 2011 Country:
United States
United States
Employees: N/A City: VANCOUVER
Market Cap: 357.9M IPO Year: 2021
Target Price: $7.98 AVG Volume (30 days): 3.0M
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.65 EPS Growth: 21.67
52 Week Low/High: $2.01 - $5.23 Next Earning Date: 03-24-2026
Revenue: $4,534,000 Revenue Growth: -20.71%
Revenue Growth (this year): 10.72% Revenue Growth (next year): 313.07%
P/E Ratio: -4.73 Index: N/A
Free Cash Flow: -72806000.0 FCF Growth: N/A

AI-Powered ABSI Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 74.39%
74.39%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Absci Corporation (ABSI)

Busch Andreas

Chief Innovation Officer

Buy
ABSI Mar 12, 2026

Avg Cost/Share

$2.29

Shares

100,000

Total Value

$229,000.00

Owned After

421,446

SEC Form 4

ABSI Feb 27, 2026

Avg Cost/Share

$2.74

Shares

75,095

Total Value

$205,760.30

Owned After

189,055

SEC Form 4

McClain Sean

Chief Executive Officer

Sell
ABSI Feb 2, 2026

Avg Cost/Share

$2.99

Shares

26,761

Total Value

$80,015.39

Owned After

8,334,567

SEC Form 4

Sell
ABSI Feb 2, 2026

Avg Cost/Share

$2.99

Shares

17,496

Total Value

$52,313.04

Owned After

383,538

SEC Form 4

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2025
Q3

Q3 2025 Earnings

8-K SELL

Nov 12, 2025 · 100% conf.

AI Prediction SELL

1D

-1.27%

$3.35

Act: -21.68%

5D

-10.13%

$3.05

Act: -15.63%

20D

-4.24%

$3.25

Act: +13.27%

Price: $3.39 Prob +5D: 0% AUC: 1.000
0001672688-25-000082

absc-202511120001672688true00016726882025-11-122025-11-12

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2025

ABSCI CORPORATION

(Exact name of registrant as specified in its charter)

Delaware 001-40646 85-3383487 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

18105 SE Mill Plain Blvd Vancouver, WA 98683 (Address of principal executive offices, including zip code) (360) 949-1041 (Registrant’s telephone number, including area code) Not Applicable (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.0001 par value per shareABSIThe Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company  ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 2.02.     Results of Operations and Financial Condition.

On November 12, 2025, Absci Corporation (the “Company”) announced its financial results for the third quarter ended September 30, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in Item 2.02 of this Current Report on Form 8-K, together with Exhibit 99.1 hereto, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 8.01.     Other Events.

From time to time, the Company presents and/or distributes slides and presentations to the investment community to provide updates and summaries of its business. On November 12, 2025, the Company released a presentation which includes certain internal pipeline program updates, which is available on the “News & Events” section of the Company’s website. A copy of this presentation is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein.

Item 9.01.    Financial Statements and Exhibits. (d) Exhibits 99.1     Press Release issued by the Company on November 12, 2025, furnished herewith. 99.2     Absci Corporate Presentation Fall 2025

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Absci Corporation

Date: November 12, 2025 By: /s/ Shelby Walker Shelby Walker Chief Legal Officer

2025
Q2

Q2 2025 Earnings

8-K/A

Aug 12, 2025

0001628280-25-039959

absc-202508120001672688true00016726882025-08-122025-08-12

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K/A

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2025

ABSCI CORPORATION

(Exact name of registrant as specified in its charter)

Delaware 001-40646 85-3383487 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

18105 SE Mill Plain Blvd Vancouver, WA 98683 (Address of principal executive offices, including zip code) (360) 949-1041 (Registrant’s telephone number, including area code) Not Applicable (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.0001 par value per shareABSIThe Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company  ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

EXPLANATORY NOTE

Absci Corporation (the “Company”) is filing this Amendment No. 1 (this “Amendment”) on Form 8-K/A to its Current Report on Form 8-K filed with the Securities and Exchange Commission on August 12, 2025 (the “Original Form 8-K”), solely to correct the reference to the date of the press release that was furnished with the Original Form 8-K as listed in Item 9.01(d) from June 12, 2025 to August 12, 2025. The date of the press release was incorrectly listed in the Original Form 8-K due to a clerical error. In addition, Item 9.01 of the Original Form 8-K was inadvertently not coded, so this Amendment also corrects that error. Except as expressly described above, this Amendment does not change the contents of the Original Form 8-K or the exhibits thereto.

Item 2.02.     Results of Operations and Financial Condition.

On August 12, 2025, Absci Corporation (the “Company”) announced its financial results for the second quarter ended June 30, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in Item 2.02 of this Current Report on Form 8-K, together with Exhibit 99.1 hereto, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 8.01.     Other Events.

From time to time, the Company presents and/or distributes slides and presentations to the investment community to provide updates and summaries of its business. On August 12, 2025, the Company released a presentation which includes certain internal pipeline program updates, which is available on the “News & Events” section of the Company’s website. A copy of this presentation is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein.

Item 9.01.    Financial Statements and Exhibits. (d) Exhibits 99.1     Press Release issued by the Company on August 12, 2025, furnished herewith. 99.2     Absci Corporate Presentation Summer 2025

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Absci Corporation

Date: August 12, 2025 By: /s/ Shelby Walker Shelby Walker Chief Legal Officer

2025
Q2

Q2 2025 Earnings

8-K

Aug 12, 2025

0001628280-25-039878

absc-202508120001672688false00016726882025-08-122025-08-12

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2025

ABSCI CORPORATION

(Exact name of registrant as specified in its charter)

Delaware 001-40646 85-3383487 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

18105 SE Mill Plain Blvd Vancouver, WA 98683 (Address of principal executive offices, including zip code) (360) 949-1041 (Registrant’s telephone number, including area code) Not Applicable (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.0001 par value per shareABSIThe Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company  ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 2.02.     Results of Operations and Financial Condition.

On August 12, 2025, Absci Corporation (the “Company”) announced its financial results for the second quarter ended June 30, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in Item 2.02 of this Current Report on Form 8-K, together with Exhibit 99.1 hereto, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 8.01.     Other Events.

From time to time, the Company presents and/or distributes slides and presentations to the investment community to provide updates and summaries of its business. On August 12, 2025, the Company released a presentation which includes certain internal pipeline program updates, which is available on the “News & Events” section of the Company’s website. A copy of this presentation is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein.

Item 9.01.    Financial Statements and Exhibits. (d) Exhibits 99.1     Press Release issued by the Company on June 12, 2025, furnished herewith. 99.2     Absci Corporate Presentation Summer 2025

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Absci Corporation

Date: August 12, 2025 By: /s/ Shelby Walker Shelby Walker Chief Legal Officer

Share on Social Networks: